Clinical trial

A Study of CX157 (TriRima) for the Treatment of Depression

NCT00739908

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention CX157 (TriRima) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of CX157 (TriRima) for the Treatment of Depression

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-09-01

PhasePHASE2

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

CX157 (TriRima)DRUG

PlaceboDRUG

Sponsors & collaborators

CeNeRx BioPharma Inc.lead sponsor

Mapped research locations

New YorkNew York, United States1 PhiladelphiaPennsylvania, United States1 SeattleWashington, United States1 BirminghamAlabama, United States1 Washington D.C.District of Columbia, United States1 AustinTexas, United States1 RaleighNorth Carolina, United States1 Beverly HillsCalifornia, United States1 RockvilleMaryland, United States1 Winter ParkFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00739908 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.